MilleGen is pleased to announce successful achievement of the first phase of a recombinant antibody library screening program for a FDA laboratory (Bethesda, MD,USA).
2007
Toulouse and les Ulis, FRANCE - March 12, 2007 MilleGen and LFB sign research partnership agreement to develop new generation of therapeutic monoclonal antibodies.
Read complete press release
